120 related articles for article (PubMed ID: 21087818)
1. DNA methylation in thoracic neoplasms.
Chen C; Yin N; Yin B; Lu Q
Cancer Lett; 2011 Feb; 301(1):7-16. PubMed ID: 21087818
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation in thymic epithelial tumors.
Chen C; Yin B; Wei Q; Li D; Hu J; Yu F; Lu Q
Cancer Invest; 2009 Jun; 27(5):582-91. PubMed ID: 19340654
[TBL] [Abstract][Full Text] [Related]
3. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state.
Kanai Y; Hirohashi S
Carcinogenesis; 2007 Dec; 28(12):2434-42. PubMed ID: 17893234
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
6. DNMT cooperativity--the developing links between methylation, chromatin structure and cancer.
El-Osta A
Bioessays; 2003 Nov; 25(11):1071-84. PubMed ID: 14579248
[TBL] [Abstract][Full Text] [Related]
7. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.
Lin RK; Hsu HS; Chang JW; Chen CY; Chen JT; Wang YC
Lung Cancer; 2007 Feb; 55(2):205-13. PubMed ID: 17140695
[TBL] [Abstract][Full Text] [Related]
8. Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.
Wang J; Bhutani M; Pathak AK; Lang W; Ren H; Jelinek J; He R; Shen L; Issa JP; Mao L
Cancer Res; 2007 Nov; 67(22):10647-52. PubMed ID: 18006804
[TBL] [Abstract][Full Text] [Related]
9. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
10. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
Wang SH; Liu NH; Wang J; Bai H; Mao L
Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA methylation in 5' regions of DNA methyltransferase genes in aborted bovine clones.
Liu J; Liang X; Zhu J; Wei L; Hou Y; Chen DY; Sun QY
J Genet Genomics; 2008 Sep; 35(9):559-68. PubMed ID: 18804075
[TBL] [Abstract][Full Text] [Related]
12. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
[TBL] [Abstract][Full Text] [Related]
13. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
Esteller M; Sanchez-Cespedes M; Rosell R; Sidransky D; Baylin SB; Herman JG
Cancer Res; 1999 Jan; 59(1):67-70. PubMed ID: 9892187
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effect of global DNA hypomethylation on gastric carcinogenesis.
Tomita H; Hirata A; Yamada Y; Hata K; Oyama T; Mori H; Yamashita S; Ushijima T; Hara A
Carcinogenesis; 2010 Sep; 31(9):1627-33. PubMed ID: 20622006
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
17. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
Kim H; Kwon YM; Kim JS; Han J; Shim YM; Park J; Kim DH
Cancer; 2006 Sep; 107(5):1042-9. PubMed ID: 16888795
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
19. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.
Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257
[TBL] [Abstract][Full Text] [Related]
20. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer.
Wang J; Walsh G; Liu DD; Lee JJ; Mao L
Cancer Res; 2006 Sep; 66(17):8361-6. PubMed ID: 16951144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
